Equities

Solara Active Pharma Sciences Ltd

SOLARA:NSI

Solara Active Pharma Sciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)749.50
  • Today's Change11.50 / 1.56%
  • Shares traded53.62k
  • 1 Year change+127.67%
  • Beta1.3015
Data delayed at least 15 minutes, as of Sep 20 2024 11:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments8487464
Total Receivables, Net3,9706,0746,037
Total Inventory3,7105,6135,800
Prepaid expenses11410084
Other current assets, total1281.608.70
Total current assets8,00811,87512,393
Property, plant & equipment, net11,14211,59111,374
Goodwill, net3,6513,6513,651
Intangibles, net426544679
Long term investments41256250
Note receivable - long term8459339
Other long term assets154151131
Total assets23,51028,99329,450
LIABILITIES
Accounts payable3,1303,0592,760
Accrued expenses544344
Notes payable/short-term debt7,6036,4886,099
Current portion long-term debt/capital leases1,3381,1781,337
Other current liabilities, total304244394
Total current liabilities12,42911,01110,634
Total long term debt1,1742,4632,937
Total debt10,11510,12910,374
Deferred income tax------
Minority interest272223
Other liabilities, total541495606
Total liabilities14,17113,99114,201
SHAREHOLDERS EQUITY
Common stock360360360
Additional paid-in capital12,16012,16012,160
Retained earnings (accumulated deficit)(3159)2,5042,747
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(23)(22)(19)
Total equity9,33915,00215,249
Total liabilities & shareholders' equity23,51028,99329,450
Total common shares outstanding393939
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.